HOME >> MEDICINE >> NEWS
Prostate cancer therapy - study suggests new molecular screening theory

(Uppsala, April 15th) -- Levels of the Smad7 protein may predict therapeutic response in patients with prostate cancer according to research published today by investigators at the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR).

"Although the 2-ME compound is in early clinical trials, no-one has fully understood the molecular mechanisms of how it causes the death of cancer cells, but not normal cells," says Dr. Marne Landstrm, the senior author of the paper published in the prestigious Journal of Biological Chemistry. "We found that 2-ME works through a protein called Smad7, and that artificially lowering the amount of Smad7 in prostate cancer cells reduced 2-ME's ability to cause cell death. This finding suggests that the levels of Smad7, and other proteins in this molecular pathway, might predict the cell-killing ability of other cancer therapeutics and thus their effectiveness for treating individual patients."

Smad7 was originally discovered at the LICR Uppsala Branch in 1997, and the team reported, in the journal Nature, that the protein stopped cell growth by inhibiting a crucial oncogene known as TGF beta. As a result of the current study, Smad7 is now thought to play a crucial role connecting the mechanisms of cell growth, governed by TGF beta, and those of cell death, governed by another oncogene, p38 MAPK.

Dr. Carl-Henrik Heldin, Director of both the Uppsala Branch and LICR's international 'TGF beta Program' cautions that the research is at a preliminary stage and that more work is now needed to investigate whether the levels of Smad7 correlate with patients' responses to different therapies. "If we can determine which patients are most likely to benefit from a particular therapeutic approach, we can reduce the possibility that a patient will undergo treatment that has side-effects but no benefit. More importantly, we may one day be able to effectively target each individual patient with the therapy-type best fo
'"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
1-212-450-1543
Ludwig Institute for Cancer Research
14-Apr-2005


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate cancer research may be faster with PSA endpoints
4. Prostate treatment decisions based on perception more than fact
5. Prostate cancer test affected by demographic and lifestyle factors
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/15/2019)... ... January 15, 2019 , ... Ophthalmic Consultants of Long Island (OCLI), ... a new, larger space at 70 East Sunrise Highway, Suite 400, Valley Stream, NY ... its patients. , According to Gerard D’Aversa, MD, “After serving the Valley Stream community ...
(Date:1/14/2019)... ... January 14, 2019 , ... Yes, the Millennials love their ... International Council on Active Aging® (ICAA), new tech is also finding a home in ... Future , queried respondents from a variety of organizations that work with older adults ...
(Date:1/14/2019)... ... January 14, 2019 , ... The Centers for ... VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of varicella in ... the CDC notes that VARIZIG is commercially available from a broad network of ...
(Date:1/14/2019)... ... January 14, 2019 , ... Specialty ... newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:1/13/2019)... ... 2019 , ... Dr. Christine Kaczmar, a functional medicine doctor in Michigan, has ... Medical Model Is Creating More Sickness And Why Timeless Healing Principles Are Needed Now". ... Dr. Christine explains that judging our health by how we feel rather than how ...
Breaking Medicine News(10 mins):
(Date:1/11/2019)... ... January 11, 2019 , ... Lynx Technology Partners (Lynx) ... US security companies for consecutive years, proudly announces their selection as a National ... that excel at employee relations, use innovation to motivate employees, implement creative compensation ...
(Date:1/10/2019)... ... January 10, 2019 , ... This week ... solutions, will crown the U.S. winner of its annual total-body transformation program, the ... of Palm Beach, Florida; Barbara Lingle of Winterville, North Carolina; Drew Key of ...
(Date:1/10/2019)... ... January 10, 2019 , ... Innovative Physical Therapy, a leading ... location, at 312 Martin Luther King Jr Blvd, Suite 102 Baltimore, MD 21201. ... healthcare professionals. , Dr. Bryan Morrow, CEO, has been providing high quality outpatient ...
Breaking Medicine Technology:
Cached News: